Recruiting NA INTERVENTIONAL 4-arm NCT06163547

Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM) (STORMM)

Middle Meningeal Artery (MMA) Embolization for cSDH: Rationale and Design for the STOp Recurrence of MMA Bleeding (STORMM) Randomized-Control Trial

Sponsor: University Hospital, Geneva

Conditions Cerebral Compression Due to Injury Chronic Subdural Hematomas

Interventions MMA embolization

Updated 6 times since 2024 Last updated: Mar 4, 2025 Started: Feb 18, 2025 Primary completion: Jan 1, 2027 Completion: Jan 1, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06163547, this NA trial focuses on Cerebral Compression Due to Injury and Chronic Subdural Hematomas and remains actively recruiting participants. Sponsored by University Hospital, Geneva, it has been updated 6 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Apr 2025 — Present [monthly]

Recruiting NA
Mar 2025 — Apr 2025 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2025 — Mar 2025 [monthly]

Not Yet Recruiting NA
Sep 2024 — Jan 2025 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jan 2024 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Geneva

Data source: University Hospital, Geneva

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Geneva, Switzerland